U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414381) titled 'An Exploratory Study of Chenghuang Circadian Rhythm Regulator in Subjects With Sleep Disorders' on Jan. 23.
Brief Summary: This is a single arm, open-label, self-controlled clinical study to evaluate the sleep and immunity improvement of Chenghuang Circadian Rhythm Regulator in adult subjects with sleep disorders.
Study Start Date: June 06, 2025
Study Type: INTERVENTIONAL
Condition:
Sleep Disorders
Intervention:
DIETARY_SUPPLEMENT: Chenghuang Circadian Rhythm Regulator
Chenghuang Circadian Rhythm Regulator was administered by PO daily 30-60 mins before bed time for 4 weeks
Recruitment Status: COMPLETED
Sponsor: Shanghai Cel...